Blue Horizon: “The Wave of Innovation That Will Be Rolling Towards Us in the Coming Years is Huge”
Bjoern Witte, Managing Partner and CEO of Blue Horizon, gives his insights into the world of alternative protein investments, the company’s plans for 2023, and his thoughts as to the future of the category. What does your current portfolio look like; in which new companies did you invest in 2022? We see a lot of very innovative companies that we source through our Seed portfolio which sort of acts like our finger on the pulse of the industry. One example of a new company we invested in this year would be Arkeon, an Austrian company that produces proteins from carbon dioxide. Arkeon’s technology makes it possible to convert CO2 directly into all 20 amino acids that are essential for human nutrition. At the same time, …